| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |